title: Interstitial granulomatous dermatitis associated with lupus: A case report.
authors.affiliation: Servicio de Reumatología, Hospital Universitari Parc Taulí de Sabadell, Sabadell, Barcelona, España. Electronic address: marevalo@tauli.cat.
authors.forename: Marta
authors.initials: M
authors.lastname: Arévalo
authors.affiliation: Servicio de Reumatología, Hospital Universitari Parc Taulí de Sabadell, Sabadell, Barcelona, España.
authors.forename: Mireia
authors.initials: M
authors.lastname: Moreno
authors.affiliation: Servicio de Reumatología, Hospital Universitari Parc Taulí de Sabadell, Sabadell, Barcelona, España.
authors.forename: Jordi
authors.initials: J
authors.lastname: Gratacós
mesh_terms: D000328:Adult; D000506:Alopecia Areata / Q000188:drug therapy / Q000209:etiology; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D001323:Autoantibodies / Q000097:blood; D003872:Dermatitis / Q000188:drug therapy / Q000209:etiology*; D057915:Drug Substitution; D004359:Drug Therapy, Combination; D006099:Granuloma / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D017495:Hyperpigmentation / Q000209:etiology; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D008297:Male; D012074:Remission Induction
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D001323:Autoantibodies; D007166:Immunosuppressive Agents; D006886:Hydroxychloroquine; C511911:belimumab